| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Aug 23, 2018 |
Director, Ten Percent Owner
Trans History: 14
|
Director, Ten Percent Owner | Form 4 | Conversion of derivative security | 784,728 | -- | 1,772,915 |
| Aug 23, 2018 |
Director, Ten Percent Owner
Trans History: 14
|
Director, Ten Percent Owner | Form 4 | Conversion of derivative security | 1,134,000 | -- | 2,906,915 |
| Aug 23, 2018 |
Director, Ten Percent Owner
Trans History: 14
|
Director, Ten Percent Owner | Form 4 | Conversion of derivative security | 8,545,184 | -- | -- |
| Aug 23, 2018 |
Director, Ten Percent Owner
Trans History: 14
|
Director, Ten Percent Owner | Form 4 | Conversion of derivative security | 6,443,565 | -- | -- |
| Aug 23, 2018 |
Director, Ten Percent Owner
Trans History: 14
|
Director, Ten Percent Owner | Form 4 | Conversion of derivative security | 27,305,708 | -- | -- |
| Aug 21, 2018 |
Director
Trans History: 18
|
Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 3,894 | $6.47 | 3,894 |
| Aug 21, 2018 |
Director
Trans History: 18
|
Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 3,894 | $6.47 | 3,894 |
| Sep 01, 2020 |
Chief Medical Officer
Trans History: 12
|
Chief Medical Officer | Form 4/A | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 300,000 | -- | 300,000 |
| Jun 30, 2020 |
Director
Trans History: 11
|
Director | Form 4/A | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 44,470 | -- | 44,470 |
| Jun 30, 2020 |
Director
Trans History: 11
|
Director | Form 4/A | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 44,470 | -- | 44,470 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.